Search research articles
Contact Us
Filters
Showing results (161-170 of 210) with videos related to
Page
of 21
Sort By:
American Journal of Hematology
|
August 12, 2020
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies
Marzia Varettoni, Angela Ferrari, Anna M Frustaci, et al.
Blood Advances
|
March 19, 2025
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi
Rexhep Durmo, Stephane Chauvie, Federico Fallanca, et al.
Hemasphere
|
December 19, 2024
Early progression beyond first-line chemoimmunotherapy in follicular lymphoma: Insights from a Fondazione Italiana Linfoma (FIL) study
Alberto Bavieri, Maria E Nizzoli, Alessandra Tucci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 3, 2017
Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma
Stefano Luminari, Angela Ferrari, Martina Manni, et al.
Hematological Oncology
|
June 17, 2020
Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity
Luigi Rigacci, Ombretta Annibali, Sofya Kovalchuk, et al.
Bone Marrow Transplantation
|
June 17, 2020
Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi
Michele Merli, Stefano Luminari, Lucia Farina, et al.
British Journal of Haematology
|
March 27, 2024
Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell Project
Monica Civallero, Joseph G Schroers-Martin, Steven Horwitz, et al.
Haematologica
|
May 12, 2018
Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the <i>Fondazione Italiana Linfomi</i>
Sergio Storti, Michele Spina, Emanuela Anna Pesce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 2022
Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi
Michele Merli, Sara Rattotti, Michele Spina, et al.
Hematological Oncology
|
September 9, 2022
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project
Carlos Chiattone, Monica Civallero, Thais Fischer, et al.
Page
of 21
Search research articles
Search
Showing results (161-170 of 210) with videos related to
Sort By:
Page
of 21
American Journal of Hematology
|
August 12, 2020
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies
Marzia Varettoni, Angela Ferrari, Anna M Frustaci, et al.
Blood Advances
|
March 19, 2025
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi
Rexhep Durmo, Stephane Chauvie, Federico Fallanca, et al.
Hemasphere
|
December 19, 2024
Early progression beyond first-line chemoimmunotherapy in follicular lymphoma: Insights from a Fondazione Italiana Linfoma (FIL) study
Alberto Bavieri, Maria E Nizzoli, Alessandra Tucci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 3, 2017
Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma
Stefano Luminari, Angela Ferrari, Martina Manni, et al.
Hematological Oncology
|
June 17, 2020
Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity
Luigi Rigacci, Ombretta Annibali, Sofya Kovalchuk, et al.
Bone Marrow Transplantation
|
June 17, 2020
Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi
Michele Merli, Stefano Luminari, Lucia Farina, et al.
British Journal of Haematology
|
March 27, 2024
Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell Project
Monica Civallero, Joseph G Schroers-Martin, Steven Horwitz, et al.
Haematologica
|
May 12, 2018
Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the <i>Fondazione Italiana Linfomi</i>
Sergio Storti, Michele Spina, Emanuela Anna Pesce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 2022
Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi
Michele Merli, Sara Rattotti, Michele Spina, et al.
Hematological Oncology
|
September 9, 2022
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project
Carlos Chiattone, Monica Civallero, Thais Fischer, et al.
Page
of 21